Monthly Communication Reports in:
June
2024
Other options for searching the Registry: 12-Month Lobbying Activity Search; Advanced Registry Search; Recent Registrations; and Recent Monthly Communication Reports.
The list below is sorted by communication date, beginning with the most recent.
Eli Lilly Canada Inc.
Kenneth L
Custer,
President and General Manager
(Corporation)
-
Eli Lilly Canada Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Judith Seidman,
Senator
|
Senate of Canada
Subject Matter of the communication:
Health
Communication date:
2024-06-27
Posted date:
2024-07-15
Communication number:
6034-609625
View associated registration
-
Eli Lilly Canada Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Michelle Boudreau,
Executive Director
|
Health Canada (HC)
-
Daniel MacDonald,
Director General, Drugs for Rare Diseases
| Strategic Policy Branch
|
Health Canada (HC)
-
Bobby Chauhan,
Director
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2024-06-06
Posted date:
2024-07-15
Communication number:
6034-609621
View associated registration
-
Eli Lilly Canada Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Paul Brogan,
Market Director
|
Invest in Canada Hub
-
Harold Dremin,
Chief Investor Services Officer
|
Invest in Canada Hub
Subject Matter of the communication:
Health,
Industry
Communication date:
2024-06-04
Posted date:
2024-07-04
Communication number:
6034-609623
(amended from
6034-609622)
View associated registration
-
Eli Lilly Canada Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Rodrigo Arancibia,
Director
| Life Science Industries Directorate
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Health
Communication date:
2024-06-02
Posted date:
2024-07-15
Communication number:
6034-609619
View associated registration
